INTRODUCTION
Urinary incontinence is a distressing condition which can have profound psychological effects on the patient, leading to social withdrawal and loss of self esteem. The financial consequences of conventional lifelong treatment of incontinence (pads and catheters) are enormous. The majority of patients suffering from urinary incontinence are female who usually respond to a bladder neck suspension procedure. Male patients and patients with neuropathic bladders need a more sophisticated approach to the problem l, In 1973 Scott 3 implanted the first artificial urinary sphincter and since then the device has undergone modifications to make it more reliable and easier to use. The advantage of the current model is that it can be left in a deactivated state until tissue healing is complete thus minimising the risk of device erosion. We describe our experience of 12 patients who had the American Medical Systems model 800TM (AMS 800) artificial sphincter inserted in a two year period.
PATIENTS AND METHODS
Twelve patients age range 19-76 (mean 48) have been treated. The clinical diagnosis, urodynamic findings and adjunctive surgical procedures for eleven are summarised in the table. All patients were assessed by clinical examination and endoscopy of the lower urinary tract. All patients had video urodynamics performed using the Aspen Medical, GaelTech GR 800 urodynamic system. Bladder capacity, intravesical pressure, and urethral pressure profiles were measured. The mechanics of the device were explained in detail to the patient, and those with neuropathic incontinence were shown how to perform clean intermittent self catheterisation. The patients were admitted for preoperative bowel preparation. Triple antibiotic therapy (gentamicin, metronidazole and penicillin) is continued for five days postoperatively. In males the device can be inserted around the bulbar urethra, the membranous urethra or around the bladder neck. In the female it can only be placed around the bladder neck. The reservoir determines the pressure in the cuff and a variety of pressures (40-50,51-60,61-70, 71-80 cm H20) can be achieved using different reservoirs. (Fig 1) . To implant an artificial urinary sphincter around the bulbar urethra, an incision is made in the perineum and the bulbar urethra is mobilised with the bulbospongiosus muscle. A measuring device is used to select the correct size of cuff. A second incision is made in either iliac fossa, and the reservoir is placed deep to the rectus abdominis in an extraperitoneal position. A subcutaneous tunnel is made into the scrotum, and the pump mechanism placed in a subcutaneous position. In the female the pump mechanism is placed in the labium majus. The device is filled with an isotonic radio-opaque solution taking great care not to allow any contamination of the tubing with blood or air. If the device is placed around the bladder neck a suprapubic approach is required (Fig 2) . The procedure is technically difficult as there is a risk of entering the vagina in the female or the rectum in the male. If this complication occurs the procedure must be abandoned. The artificial sphincter is designed to produce a bladder outlet resistance in the range of pressures as described above. The design of the device allows rises in intra-abdominal pressure to be transmitted to the cuff. This usually occurs relatively slowly, but if intra-abdominal pressure rises very quickly, as when getting up from a low chair, slight stress incontinence may occur. This has an important bearing on patient selection, as patients with spina bifida in wheelchairs generate high intra-abdominal pressures when trying to move themselves in the wheelchair, as do those who walk with elbow crutches. Pre-operative assessment of the patient, treatment of any urinary tract infection, dermatitis or other foci of infection is essential before inserting the device.
Patients should be prepared to perform clean intermittent self-catheterisation if necessary. This is an important part of the management of the neuropathic bladder to eliminate residual urine consequent on inefficient bladder emptying. After insertion of an artificial urinary sphincter in patients with neuropathy, or in those who have had a cystoplasty, bladder emptying may be further impaired and some patients may need to perform self-catheterisation through the sphincter cuff to eliminate residual urine.
Video urodynamics are essential to accurately measure bladder pressure, capacity and sphincter function . The anatomy of the bladder and bladder neck can be visualised and vesicoureteric reflux identified 4. Careful endoscopy is needed to ensure that the patient's urethra is normal and any stricture or urethral disease should be treated before inserting the device. The bladder must be of adequate capacity to allow the patient to hold urine for a socially acceptable time. The bladder must also be capable of storing urine at low pressure in order to protect the upper renal tracts. It is imperative to treat any detrusor instability with anticholinergics. If medical treatment of instability fails then the surgical procedure of choice is an ileocystoplasty (the "clam" procedure). The major complication following implantation is infection leading to erosion. If this occurs, the device must be removed, as healing will not occur in the presence of a foreign body. Mundy2 has identified patients who are at risk for this and quotes 15% infection erosion rate in patients with neuropathic bladders. In patients who have had a sling operation around the bladder neck or in any patient who has had pelvic radiotherapy the infection erosion rate is over 50%. Thus, previous sling surgery or radiotherapy is a contra-indication to insertion of an artificial urinary sphincter 6' 7. Erosion rates are higher in elderly patients or when the device is implanted around the bulbar urethra as opposed to the bladder neck. Although implantation around the bladder neck has a lower rate of erosion, the operative procedure is more difficult and is associated with greater morbidity.
Patients with incontinence as a result of major trauma may have such extensive fibrosis at the bladder neck as to preclude implantation at this site. Erosion is also more frequent when higher pressure reservoirs are used and it is our practice to implant a low pressure reservoir initially, changing to a higher pressure if incontinence persists.
The major alternative to implantation of an artificial urinary sphincter is reconstruction of the bladder neck or a urinary diversion. Continent urinary diversions are associated with a high complication rate, with the obvious disadvantages of needing a stoma which has to be catheterised. Successful implantation of an artificial sphincter offers a better quality of life. This procedure does not have a place in the first line of treatment of stress incontinence in females and is only used for complex cases following failed anti-stress procedures.
The overall success rate of the artificial urinary sphincter is about 95%, with 5% being persistent failures. The major complications are infection and erosion, which occur in 10%-1 5% of patients. Two percent of the devices develop early mechanical failure and a further 2% develop late longterm failures usually due to leakage from the cuff. Our experience indicates that with careful patient selection excellent results can be achieved with the artificial urinary sphincter. It is the procedure of choice for patients with post-prostatectomy incontinence. It is ideal for certain patients with neuropathic bladder dysfunction who are highly motivated and have normal hand function.
